|
1
|
Kelly T, Børset M, Abe E, Gaddy-Kurten D
and Sanderson RD: Matrix metalloproteinases in multiple myeloma.
Leuk Lymphoma. 37:273–281. 2000.PubMed/NCBI
|
|
2
|
Barillé S, Akhoundi C, Collette M,
Mellerin MP, Rapp MJ, Harousseau JL, Bataille R and Amiot M:
Metalloproteinases in multiple myeloma: Production of matrix
metalloproteinase-9 (MMP-9), activation of proMMP-2 and induction
of MMP-1 by myeloma cells. Blood. 90:1649–1655. 1997.
|
|
3
|
He X, Yang K, Chen P, Liu B, Zhang Y, Wang
F, Guo Z, Liu X, Lou J and Chen H: Arsenic trioxide-based therapy
in relapsed/refractory multiple myeloma patients: A meta-analysis
and systematic review. Onco Targets Ther. 7:1593–1599. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hameed A, Brady JJ, Dowling P, Clynes M
and O'Gorman P: Bone disease in multiple myeloma: Pathophysiology
and management. Cancer Growth Metastasis. 7:33–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fuchs O: Targeting of NF-kappaB signaling
pathway, other signaling pathways and epigenetics in therapy of
multiple myeloma. Cardiovasc Hematol Disord Drug Targets. 13:16–34.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manni S, Brancalion A, Mandato E, Tubi LQ,
Colpo A, Pizzi M, Cappellesso R, Zaffino F, Di Maggio SA, Cabrelle
A, et al: Protein kinase CK2 inhibition down modulates the NF-κB
and STAT3 survival pathways, enhances the cellular proteotoxic
stress and synergistically boosts the cytotoxic effect of
bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS
One. 8:e752802013. View Article : Google Scholar
|
|
7
|
Gatt ME, Takada K, Mani M, Lerner M, Pick
M, Hideshima T, Carrasco DE, Protopopov A, Ivanova E, Sangfelt O,
et al: TRIM13 (RFP2) downregulation decreases tumour cell growth in
multiple myeloma through inhibition of NF Kappa B pathway and
proteasome activity. Br J Haematol. 162:210–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ni H, Zhao W, Kong X, Li H and Ouyang J:
NF-kappa B modulation is involved in celastrol induced human
multiple myeloma cell apoptosis. PLoS One. 9:e958462014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou JJ, Zheng S, Sun LF and Zheng L:
MicroRNA regulation network in colorectal cancer metastasis. World
J Biol Chem. 5:301–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo X, Gu J, Zhu R, Feng M, Zhu X, Li Y
and Fei J: Integrative analysis of differential miRNA and
functional study of miR-21 by seed-targeting inhibition in multiple
myeloma cells in response to berberine. BMC Syst Biol. 8:822014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jagannathan S, Vad N, Vallabhapurapu S,
Vallabhapurapu S, Anderson KC and Driscoll JJ: MiR-29b replacement
inhibits proteasomes and disrupts aggresome+autophagosome formation
to enhance the anti-myeloma benefit of bortezomib. Leukemia.
29:727–738. 2015. View Article : Google Scholar :
|
|
12
|
Zhang YK, Wang H, Leng Y, Li ZL, Yang YF,
Xiao FJ, Li QF, Chen XQ and Wang LS: Overexpression of microRNA-29b
induces apoptosis of multiple myeloma cells through down regulating
Mcl-1. Biochem Biophys Res Commun. 414:233–239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qian K, Gao AJ, Zhu MY, Shao HX, Jin WJ,
Ye JQ and Qin AJ: Genistein inhibits the replication of avian
leucosis virus subgroup J in DF-1 cells. Virus Res. 192:114–120.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki R, Kang Y, Li X, Roife D, Zhang R
and Fleming JB: Genistein potentiates the antitumor effect of
5-Fluorouracil by inducing apoptosis and autophagy in human
pancreatic cancer cells. Anticancer Res. 34:4685–4692.
2014.PubMed/NCBI
|
|
15
|
Choi EJ, Jung JY and Kim GH: Genistein
inhibits the proliferation and differentiation of MCF-7 and 3T3-L1
cells via the regulation of ERα expression and induction of
apoptosis. Exp Ther Med. 8:454–458. 2014.PubMed/NCBI
|
|
16
|
Li J, Li J, Yue Y, Hu Y, Cheng W, Liu R,
Pan X and Zhang P: Genistein suppresses tumor necrosis factor
α-induced inflammation via modulating reactive oxygen
species/Akt/nuclear factor κB and adenosine monophosphate-activated
protein kinase signal pathways in human synoviocyte MH7A cells.
Drug Des Devel Ther. 8:315–323. 2014. View Article : Google Scholar
|
|
17
|
Jamadar-Shroff V, Papich MG and Suter SE:
Soy-derived isoflavones inhibit the growth of canine lymphoid cell
lines. Clin Cancer Res. 15:1269–1276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen HF, Li ZY, Tang JQ, Shen HS, Cui QY,
Ren YY, Qin LM, Jin LJ, Zhu JJ, Wang J, et al: Clinical study of
thalidomide combined with dexamethasone for the treatment of
elderly patients with newly diagnosed multiple myeloma. Asian Pac J
Cancer Prev. 13:4777–4781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamura H and Wang Y, Xue H, Romanish MT,
Mager DL, Helgason CD and Wang Y: Genistein versus ICI 182, 780: An
ally or enemy in metastatic progression of prostate cancer.
Prostate. 73:1747–1760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue JP, Wang G, Zhao ZB, Wang Q and Shi Y:
Synergistic cytotoxic effect of genistein and doxorubicin on
drug-resistant human breast cancer MCF-7/Adr cells. Oncol Rep.
32:1647–1653. 2014.PubMed/NCBI
|
|
21
|
Zhang GJ and Zhang Z: Effect of Bcl-2 on
apoptosis and transcription factor NF-κB activation induced by
adriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer
Prev. 14:2387–2391. 2013. View Article : Google Scholar
|
|
22
|
Li Z, Yang Z, Peng X, Li Y, Liu Q and Chen
J: Nuclear factor-κB is involved in the protocadherin-10-mediated
pro-apoptotic effect in multiple myeloma. Mol Med Rep. 10:832–838.
2014.PubMed/NCBI
|
|
23
|
Luo Y, Wang SX, Zhou ZQ, Wang Z, Zhang YG,
Zhang Y and Zhao P: Apoptotic effect of genistein on human colon
cancer cells via inhibiting the nuclear factor-kappa B (NF-κB)
pathway. Tumour Biol. 35:11483–11488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung MH, Kim DH, Na HK, Kim JH, Kim HN,
Haegeman G and Surh YJ: Genistein inhibits phorbol ester-induced
NF-κB transcriptional activity and COX-2 expression by blocking the
phosphorylation of p65/Rel in human mammary epithelial cells. Mutat
Res. 768:74–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amodio N, Bellizzi D, Leotta M, Raimondi
L, Biamonte L, D'Aquila P, Di Martino MT, Calimeri T, Rossi M,
Lionetti M, et al: miR-29b induces SOCS-1 expression by promoter
demethylation and negatively regulates migration of multiple
myeloma and endothelial cells. Cell Cycle. 12:3650–3662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL and Dahiya R: Genistein downregulates
onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation
and histone modification in prostate cancer cells. Br J Cancer.
110:1645–1654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia J, Cheng L, Mei C, Ma J, Shi Y, Zeng F
and Wang Z and Wang Z: Genistein inhibits cell growth and invasion
through regulation of miR-27a in pancreatic cancer cells. Curr
Pharm Des. 20:5348–5353. 2014. View Article : Google Scholar : PubMed/NCBI
|
